The National Ovarian Cancer Early Detection Program at Mount Sinai
The National Ovarian Cancer Early Detection Program at Mount Sinai
When ovarian cancer strikes, everyone is affected: patients, spouses, children, parents, friends. Every 24 minutes, a woman is diagnosed with ovarian cancer (almost 22,000 new cases every year). "Every day that passes without a cure means the suffering and death of countless women," says David Fishman, MD, Director of the National Ovarian Cancer Early Detection Program (NOCED) at Mount Sinai. "Our number one priority is to help save women's lives. There's nothing more rewarding than that." At Mount Sinai, we believe that the best treatment begins with early detection. Learn more at http://bit.ly/ogg7L0Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.